[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100641650":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":11,"centralContacts":31,"locations":40,"responsibleParty":417,"collaborators":11,"id":419,"slug":420,"hasResults":421,"nctId":422,"briefTitle":423,"officialTitle":424,"acronym":11,"eligibilityCriteria":425,"healthyVolunteers":421,"sex":426,"minAge":427,"maxAge":11,"enrollmentInfo":428,"targetDuration":11,"studyType":431,"phases":432,"briefSummary":434,"conditions":435,"keywords":438,"overallStatus":43,"whyStopped":11,"lastUpdateSubmitDate":446,"lastUpdatePostDateStruct":447,"startDateStruct":450,"completionDateStruct":452,"leadSponsor":454,"locationsCount":455},{"fullName":5,"class":6},"Verastem, Inc.","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"VS-7375 Monotherapy","EXPERIMENTAL",null,[13],"Drug: VS-7375",{"label":15,"type":10,"description":11,"interventionNames":16},"VS-7375 + cetuximab 2L PDAC",[13,17],"Drug: cetuximab",{"label":19,"type":10,"description":11,"interventionNames":20},"VS-7375 + cetuximab 1L PDAC",[13,17],[22,27],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":11},"DRUG","VS-7375","Taken by mouth",[19,15,9],{"type":23,"name":28,"description":29,"armGroupLabels":30,"otherNames":11},"cetuximab","Subcutaneous infusion",[19,15],[32,37],{"name":33,"role":34,"phone":35,"phoneExt":11,"email":36},"Verastem Call Center","CONTACT","7812924204","VS-7375-201TrialSupport@verastem.com",{"name":38,"role":34,"phone":11,"phoneExt":11,"email":39},"Luke Chung, MD","VS-7375-201Medical@verastem.com",[41,62,75,88,104,120,136,149,166,179,195,209,225,241,258,272,288,301,317,334,349,366,383,402],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"START- Los Angeles","RECRUITING","Los Angeles","California","90025","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-118.24368,34.05223,{"lat":53,"lon":52},[56,59],{"name":57,"role":34,"phone":11,"phoneExt":11,"email":58},"Hope Team","hopeteam@startresearch.com",{"name":60,"role":61,"phone":11,"phoneExt":11,"email":11},"Navid Hafez, MD","PRINCIPAL_INVESTIGATOR",{"facility":63,"status":43,"city":44,"state":45,"zip":64,"country":47,"countryCode":48,"cosmosGeoPoint":65,"geoPoint":67,"contacts":68},"Cedars-Sinai Medical Center","90048",{"type":50,"coordinates":66},[52,53],{"lat":53,"lon":52},[69,73],{"name":70,"role":34,"phone":71,"phoneExt":11,"email":72},"Zachariah Brown","310-423-5618","Zachariah.Brown@cshs.org",{"name":74,"role":61,"phone":11,"phoneExt":11,"email":11},"Arsen Osipov, MD",{"facility":76,"status":43,"city":44,"state":45,"zip":77,"country":47,"countryCode":48,"cosmosGeoPoint":78,"geoPoint":80,"contacts":81},"Valkyrie Clinical Trials","90067",{"type":50,"coordinates":79},[52,53],{"lat":53,"lon":52},[82,86],{"name":83,"role":34,"phone":84,"phoneExt":11,"email":85},"Trenis Palmer","4245351874","trenis.palmer@vctcare.com",{"name":87,"role":61,"phone":11,"phoneExt":11,"email":11},"David Berz, MD",{"facility":89,"status":43,"city":90,"state":91,"zip":92,"country":47,"countryCode":48,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Moffitt Cancer Center","Tampa","Florida","33612",{"type":50,"coordinates":94},[95,96],-82.45843,27.94752,{"lat":96,"lon":95},[99,102],{"name":100,"role":34,"phone":11,"phoneExt":11,"email":101},"Brianna Holder","Brianna.Holder@moffitt.org",{"name":103,"role":61,"phone":11,"phoneExt":11,"email":11},"Dae-Won Kim, MD",{"facility":105,"status":43,"city":106,"state":107,"zip":108,"country":47,"countryCode":48,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Johns Hopkins University","Baltimore","Maryland","21287",{"type":50,"coordinates":110},[111,112],-76.61219,39.29038,{"lat":112,"lon":111},[115,118],{"name":116,"role":34,"phone":11,"phoneExt":11,"email":117},"Colleen Apostol","apostco@jhmi.edu",{"name":119,"role":61,"phone":11,"phoneExt":11,"email":11},"Mari Nakazawa, MD",{"facility":121,"status":43,"city":122,"state":123,"zip":124,"country":47,"countryCode":48,"cosmosGeoPoint":125,"geoPoint":129,"contacts":130},"Massachusetts General Hospital","Boston","Massachusetts","02114",{"type":50,"coordinates":126},[127,128],-71.05977,42.35843,{"lat":128,"lon":127},[131,135],{"name":132,"role":34,"phone":133,"phoneExt":11,"email":134},"Harshabad Singh, MD","617-724-4000","sharshabad@mgb.org",{"name":132,"role":61,"phone":11,"phoneExt":11,"email":11},{"facility":137,"status":43,"city":122,"state":123,"zip":138,"country":47,"countryCode":48,"cosmosGeoPoint":139,"geoPoint":141,"contacts":142},"Dana-Farber Cancer Institute","02215",{"type":50,"coordinates":140},[127,128],{"lat":128,"lon":127},[143,147],{"name":144,"role":34,"phone":145,"phoneExt":11,"email":146},"Danielle Lindquist","857-215-2351","DanielleA_Lindquist@DFCI.HARVARD.EDU",{"name":148,"role":61,"phone":11,"phoneExt":11,"email":11},"Kimberly Perez, MD",{"facility":150,"status":43,"city":151,"state":152,"zip":153,"country":47,"countryCode":48,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"University of Michigan","Ann Arbor","Michigan","48109",{"type":50,"coordinates":155},[156,157],-83.74088,42.27756,{"lat":157,"lon":156},[160,164],{"name":161,"role":34,"phone":162,"phoneExt":11,"email":163},"Cancer Answer Line","1-800-865-1125","CancerAnswerLine@med.umich.edu",{"name":165,"role":61,"phone":11,"phoneExt":11,"email":11},"Vaibhav Sahai, MD",{"facility":167,"status":43,"city":168,"state":152,"zip":169,"country":47,"countryCode":48,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"START Midwest","Grand Rapids","49546",{"type":50,"coordinates":171},[172,173],-85.66809,42.96336,{"lat":173,"lon":172},[176,177],{"name":57,"role":34,"phone":11,"phoneExt":11,"email":58},{"name":178,"role":61,"phone":11,"phoneExt":11,"email":11},"Sreenivasa Chandana, MD",{"facility":180,"status":43,"city":181,"state":182,"zip":183,"country":47,"countryCode":48,"cosmosGeoPoint":184,"geoPoint":188,"contacts":189},"Washington University","St Louis","Missouri","63110",{"type":50,"coordinates":185},[186,187],-90.19789,38.62727,{"lat":187,"lon":186},[190,193],{"name":191,"role":34,"phone":11,"phoneExt":11,"email":192},"Olive Pressey","olive@wustl.edu",{"name":194,"role":61,"phone":11,"phoneExt":11,"email":11},"Kian-Huat Lim, MD",{"facility":196,"status":43,"city":197,"state":198,"zip":199,"country":47,"countryCode":48,"cosmosGeoPoint":200,"geoPoint":204,"contacts":205},"START New Jersey","East Brunswick","New Jersey","08816",{"type":50,"coordinates":201},[202,203],-74.41598,40.42788,{"lat":203,"lon":202},[206,207],{"name":57,"role":34,"phone":11,"phoneExt":11,"email":58},{"name":208,"role":61,"phone":11,"phoneExt":11,"email":11},"Bruno Fang, MD",{"facility":210,"status":43,"city":211,"state":211,"zip":212,"country":47,"countryCode":48,"cosmosGeoPoint":213,"geoPoint":217,"contacts":218},"NYU-Manhattan","New York","10016",{"type":50,"coordinates":214},[215,216],-74.00597,40.71427,{"lat":216,"lon":215},[219,223],{"name":220,"role":34,"phone":221,"phoneExt":11,"email":222},"Monica Dureja","2122634415","Monica.Dureja@nyulangone.org",{"name":224,"role":61,"phone":11,"phoneExt":11,"email":11},"Kristen Spencer, MD",{"facility":226,"status":43,"city":227,"state":228,"zip":229,"country":47,"countryCode":48,"cosmosGeoPoint":230,"geoPoint":234,"contacts":235},"University of North Carolina","Chapel Hill","North Carolina","27599",{"type":50,"coordinates":231},[232,233],-79.05584,35.9132,{"lat":233,"lon":232},[236,239],{"name":237,"role":34,"phone":11,"phoneExt":11,"email":238},"Catherine Griffin","catherine_griffin@med.unc.edu",{"name":240,"role":61,"phone":11,"phoneExt":11,"email":11},"Ashwin Somasundaram, MD",{"facility":242,"status":43,"city":243,"state":244,"zip":245,"country":47,"countryCode":48,"cosmosGeoPoint":246,"geoPoint":250,"contacts":251},"Sarah Cannon Research Institute","Nashville","Tennessee","37203",{"type":50,"coordinates":247},[248,249],-86.78444,36.16589,{"lat":249,"lon":248},[252,256],{"name":253,"role":34,"phone":254,"phoneExt":11,"email":255},"Karlie Williams","6153297274","Karlie.Williams@scri.com",{"name":257,"role":61,"phone":11,"phoneExt":11,"email":11},"Meredith Pelster, MD",{"facility":259,"status":43,"city":260,"state":261,"zip":262,"country":47,"countryCode":48,"cosmosGeoPoint":263,"geoPoint":267,"contacts":268},"START Dallas","Fort Worth","Texas","76104",{"type":50,"coordinates":264},[265,266],-97.32085,32.72541,{"lat":266,"lon":265},[269,270],{"name":57,"role":34,"phone":11,"phoneExt":11,"email":58},{"name":271,"role":61,"phone":11,"phoneExt":11,"email":11},"Salwan Almutar, MD",{"facility":273,"status":43,"city":274,"state":261,"zip":275,"country":47,"countryCode":48,"cosmosGeoPoint":276,"geoPoint":280,"contacts":281},"MD Anderson Cancer Center","Houston","77054",{"type":50,"coordinates":277},[278,279],-95.36327,29.76328,{"lat":279,"lon":278},[282,286],{"name":283,"role":34,"phone":284,"phoneExt":11,"email":285},"Michelle Escano-Caballero","7137941776","MEscano@mdanderson.org",{"name":287,"role":61,"phone":11,"phoneExt":11,"email":11},"Shubham Pant, MD",{"facility":289,"status":43,"city":290,"state":261,"zip":291,"country":47,"countryCode":48,"cosmosGeoPoint":292,"geoPoint":296,"contacts":297},"START- San Antonio","San Antonio","78229",{"type":50,"coordinates":293},[294,295],-98.49363,29.42412,{"lat":295,"lon":294},[298,299],{"name":57,"role":34,"phone":11,"phoneExt":11,"email":58},{"name":300,"role":61,"phone":11,"phoneExt":11,"email":11},"Drew Rasco, MD",{"facility":302,"status":43,"city":303,"state":304,"zip":305,"country":47,"countryCode":48,"cosmosGeoPoint":306,"geoPoint":310,"contacts":311},"START- Mountain Region","West Valley City","Utah","84119",{"type":50,"coordinates":307},[308,309],-112.00105,40.69161,{"lat":309,"lon":308},[312,315],{"name":313,"role":34,"phone":11,"phoneExt":11,"email":314},"Julianna Daley","Julianna.daley@startresearch.com",{"name":316,"role":61,"phone":11,"phoneExt":11,"email":11},"William McKean, MD",{"facility":318,"status":43,"city":319,"state":320,"zip":321,"country":47,"countryCode":48,"cosmosGeoPoint":322,"geoPoint":326,"contacts":327},"UVA Health","Charlottesville","Virginia","22903",{"type":50,"coordinates":323},[324,325],-78.47668,38.02931,{"lat":325,"lon":324},[328,332],{"name":329,"role":34,"phone":330,"phoneExt":11,"email":331},"Clinical Trials Navigator","4349820539","UVACANCERTRIALS@uvahealth.org",{"name":333,"role":61,"phone":11,"phoneExt":11,"email":11},"Matthew Reilley, MD",{"facility":335,"status":43,"city":336,"state":320,"zip":337,"country":47,"countryCode":48,"cosmosGeoPoint":338,"geoPoint":342,"contacts":343},"Virginia Cancer Specialists","Fairfax","22031",{"type":50,"coordinates":339},[340,341],-77.30637,38.84622,{"lat":341,"lon":340},[344,347],{"name":345,"role":34,"phone":11,"phoneExt":11,"email":346},"Melissa Hackmaster","melissa.hackmaster@usoncology.com",{"name":348,"role":61,"phone":11,"phoneExt":11,"email":11},"Alexander Spira, MD",{"facility":350,"status":43,"city":351,"state":352,"zip":353,"country":47,"countryCode":48,"cosmosGeoPoint":354,"geoPoint":358,"contacts":359},"Virginia Mason","Seattle","Washington","98101",{"type":50,"coordinates":355},[356,357],-122.33207,47.60621,{"lat":357,"lon":356},[360,364],{"name":361,"role":34,"phone":362,"phoneExt":11,"email":363},"Kara Turner","206-341-1245","Kara.Turner@commonspirit.org",{"name":365,"role":61,"phone":11,"phoneExt":11,"email":11},"Vincent Picozzi, MD",{"facility":367,"status":43,"city":368,"state":369,"zip":370,"country":47,"countryCode":48,"cosmosGeoPoint":371,"geoPoint":375,"contacts":376},"UW Health","Madison","Wisconsin","53792",{"type":50,"coordinates":372},[373,374],-89.40123,43.07305,{"lat":374,"lon":373},[377,381],{"name":378,"role":34,"phone":379,"phoneExt":11,"email":380},"Cancer Connect","8006228922","cancerconnect@uwhealth.org",{"name":382,"role":61,"phone":11,"phoneExt":11,"email":11},"Noelle LoConte, MD",{"facility":384,"status":43,"city":385,"state":386,"zip":387,"country":388,"countryCode":389,"cosmosGeoPoint":390,"geoPoint":394,"contacts":395},"ICON Kurralta Park","Kurralta Park","South Australia","5037","Australia","AU",{"type":50,"coordinates":391},[392,393],138.56702,-34.95142,{"lat":393,"lon":392},[396,400],{"name":397,"role":34,"phone":398,"phoneExt":11,"email":399},"Sarah Gartland","08 84740420","Sarah.gartland@icon.team",{"name":401,"role":61,"phone":11,"phoneExt":11,"email":11},"Carolyn Bampton, MD",{"facility":403,"status":43,"city":404,"state":11,"zip":405,"country":388,"countryCode":389,"cosmosGeoPoint":406,"geoPoint":410,"contacts":411},"ICON Cancer Centre","South Brisbane","QLD 4101",{"type":50,"coordinates":407},[408,409],153.02049,-27.48034,{"lat":409,"lon":408},[412,415],{"name":413,"role":34,"phone":11,"phoneExt":11,"email":414},"Apryl Chelin","Apryl.chelin@icon.team",{"name":416,"role":61,"phone":11,"phoneExt":11,"email":11},"Jermaine Coward, MD",{"type":418,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100641650","phase-2-a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-pancreatic-cancer-100641650",false,"NCT07644559","A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer","A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON\u002FOFF) Inhibitor, as Monotherapy and With Cetuximab, in Patients With Metastatic KRAS G12D-Mutated Pancreatic Cancer (TARGET-D 201)","Inclusion Criteria:\n\n* Histopathology confirmed PDAC\n* Measurable disease per RECIST 1.1\n* Local testing confirmed KRAS G12D mutation (tissue required for confirmatory central testing)\n* ECOG PS=0 or 1\n\nAdequate organ function\n\nVS-7375 + cetuximab (2L PDAC) :\n\n-Received only 1 prior Tx in the metastatic setting; prior adjuvant counts as a line if progressed within 6 months\n\nVS-7375 + cetuximab (1L PDAC) :\n\n-Treatment-naïve or received ≤ 1 cycle of SoC for metastatic disease\n\nExclusion criteria:\n\n* Have any other documented co-existing common RAS mutation(s)\n* Prior anti-cancer Tx within 4 weeks or drug-specific timeline within first treatment dose, whichever shorter\n* Major surgery within 4 weeks of first treatment dose\n* Radiation therapy (RT) within 1 week of first treatment dose; RT to brain or lung within 2 weeks of first treatment dose\n* History of drug-induced Interstitial Lung Disease\n* Receipt of prior direct RAS inhibitor\n* Untreated or symptomatic CNS metastasis\n* Receipt of strong CYP3A4 inhibitor\u002Finducer or CYP3A4 sensitive substrates with narrow therapeutic index within 14 days or drug-specific timeline within first treatment dose, whichever is shorter\n* Receipt of PPI or H2 blocker within 5 days\n* Inability to swallow oral medication\n* Other protocol-defined inclusion\u002Fexclusion criteria may apply","ALL","18 Years",{"count":429,"type":430},180,"ESTIMATED","INTERVENTIONAL",[433],"PHASE2","This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic Cancer",[436,437],"Pancreatic Ductal Adenocarcinoma (PDAC)","G12D Mutated KRAS",[439,440,441,442,443,444,445],"KRAS G12D mutation","KRAS","PDAC","Pancreatic Ductal Adenocarcinoma","Pancreatic Cancer","Pancreatic Neoplasms","RAS","2026-08-13",{"date":448,"type":449},"2026-08-17","ACTUAL",{"date":451,"type":449},"2026-06-16",{"date":453,"type":430},"2028-12",{"name":5,"class":6},24]